Guggenheim Securities Downgrades Aegerion Pharmaceuticals To Sell


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Guggenheim Securities downgraded

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) from Neutral to Sell.Aegerion Pharmaceuticals shares have dropped 39.92 percent over the past 52 weeks, while the S&P 500 index has surged 5.01 percent in the same period.Aegerion Pharmaceuticals' shares fell 2.47 percent to $18.13 in pre-market trading.
Posted In: DowngradesAnalyst RatingsGuggenheim Securities